Time interval between diagnosis to treatment of breast cancer and the impact of health insurance coverage: a sub analysis of the AMAZONA III Study (GBECAM 0115)
Tomas Reinert, Susana Ramalho, Vivian CA Vasconcelos, Leonardo R Silva, Ana Elisa R Silva, Camila A Andrade, Maria Beatriz PL Kraft, Guilherme P Coelho, Jovana Mandelli, Monique Binotto, Cesar Cabello, Geisilene RP Silva, Jose Bines, Carlos H Barrios, Matthew J Ellis and Marcia S Graudenz.
Time interval between diagnosis to treatment of breast cancer and the impact of health insurance coverage: a sub analysis of the AMAZONA III Study (GBECAM 0115)
Raíra Mesquita Maschmann, Rafaela Gomes De Jesus, Gustavo Werutsky, Taiane Francieli Rebelatto, Geraldo Queiroz, Sergio Daniel Simon, José Bines, Carlos Henrique Escosteguy Barrios & Daniela Dornelles Rosa DOI: 10.1007/s10549-022-06809-8 Full link: https://link.springer.com/article/10.1007/s10549-022-06809-8
Targeted Therapy for Locally Advanced or Metastatic Urothelial Cancer (mUC): Therapeutic Potential of Sacituzumab Govitecan
Mariane S Fontes, Daniel Vargas Pivato de Almeida, Clarissa Cavalin, Scott T Tagawa DOI: 10.2147/OTT.S339348 Full link: https://www.dovepress.com/targeted-therapy-for-locally-advanced-or-metastatic-urothelial-cancer--peer-reviewed-fulltext-article-OTT
Management of patients with early-stage triple-negative breast cancer following pembrolizumab-based neoadjuvant therapy: What are the evidences?
Renata Colombo Bonadio, Paolo Tarantino, Laura Testa, Kevin Punie, Sonia Pernas, Carlos Barrios, Giuseppe Curigliano, Sara M Tolaney, Romualdo Barroso-Sousa DOI: 10.1016/j.ctrv.2022.102459 Full link: https://linkinghub.elsevier.com/retrieve/pii/S0305737222001281
Multicenter Database of Patients with Germ-Cell Tumors: A Latin American Cooperative Oncology Group Regristry (LACOG 0515)
Tomas Reinert, Susana Ramalho, Vivian CA Vasconcelos, Leonardo R Silva, Ana Elisa R Silva, Camila A Andrade, Maria Beatriz PL Kraft, Guilherme P Coelho, Jovana Mandelli, Monique Binotto, Cesar Cabello, Geisilene RP Silva, Jose Bines, Carlos H Barrios, Matthew J Ellis and Marcia S Graudenz.
Barriers in access to oncology drugs – a global crisis
Carlos Barrios, Gilberto de Lima Lopes, Mastura Md Yusof, Fidel Rubagumya, Piotr Rutkowski, Manju Sengar DOI: 10.1038/s41571-022-00700-7 Full link: https://www.nature.com/articles/s41571-022-00700-7
Impact of the COVID-19 Pandemic on Cancer Staging: An Analysis of Patients With Breast Cancer From a Community Practice in Brazil
Cristiano A A Resende, Heloísa M Fernandes Cruz, Matheus Costa E Silva, Rafael D Paes, Rodrigo Dienstmann, Carlos H E Barrios, Aline C Goncalves, Fanny G A Cascelli, Andreza K B A Souto, Leandro C Oliveira, Tomás Reinert, Diocesio A P Andrade, Mauro P Passos , Eduardo C Millen, Felipe Zerwes, Paulo L Moraes, Bruno L Ferrari, Max S Mano DOI: 10.1200/GO.22.00289 Full link: https://ascopubs.org/doi/10.1200/GO.22.00289
Clinical implication of low estrogen receptor (ER-low) expression in breast cancer
Tomás Reinert, Fanny Cascelli, Cristiano Augusto Andrade de Resende, Aline Coelho Gonçalves, Vania Sanchez Prette Godo, Carlos Henrique Barrios DOI: 10.3389/fendo.2022.1015388 Full link: https://www.frontiersin.org/articles/10.3389/fendo.2022.1015388/full
Oral Lichen Planus and Oral Squamous Cell Carcinoma share key oncogenic signatures
Cristóvão Antunes de Lanna, Beatriz Nascimento Monteiro da Silva, Andreia Cristina de Melo, Martín H Bonamino, Lísia Daltro Borges Alves, Luis Felipe Ribeiro Pinto, Abel Silveira Cardoso, Héliton Spíndola Antunes, Mariana Boroni, Daniel Cohen Goldemberg DOI: 10.1038/s41598-022-24801-6 Full link: https://www.nature.com/articles/s41598-022-24801-6
Radiotherapy activity in the Covid-19 pandemic: Brazil´s operational national-level study
Fabio Y. Moraes, Andre G. Gouveia , Renato P. Lima, Gustavo A. Viani, Vanessa F. Brassati, Ana C. Hamamura DOI: 10.1016/j.jcpo.2022.100367 Full link: https://www.sciencedirect.com/science/article/pii/S2213538322000467